Evidence that iron overload plus croton oil induce skin tumours in mice

Abstract

Iron overload is known to occur due to different factors including genetic disorders. It has been shown that iron overload predisposes humans to an increased risk of cancer. However, the mechanism by which iron overload enhances chemically induced carcinogenesis is not known. In this report, for the first time it is shown that iron overload acts as a tumour initiator. Female albino Swiss mice were given iron dextran 1 mg/mouse per day intramuscularly for 15 days and croton oil 0.5 mg in 200 mL acetone/mouse topically twice a week for 30 weeks. During this period, the animals were observed for tumour incidence. There were significantly higher yields of tumours in those animals receiving both iron and croton oil. However, the group of animals treated only with acetone, iron, croton oil and 7,12-dimethylben-z(a)anthracene (DMBA) alone did not develop any tumours during 30 weeks of observation. Further, croton oil-mediated induction in cutaneous lipid peroxidation (LPO) level was higher in the iron-overload group. The results of this study suggest that oxidative stress generated by iron overload is responsible for croton oilmediated skin carcinogenesis.

Keywords

croton oil iron overload skin tumorigenesis

References

1 Conard ME , Uzel C , Berry M , Latour L. Ironic catastrophes; one's food another's poison . Am J Med Sci 1994; 307: 434–437 .

2 Herbert V , Shaw S , Javatilleke E , Stopler KT . Most free radical injury is iron-related: it is promoted by iron, hematin, holoferritin and vitamin C and inhibited by desferroxamine and apoferritin . Stem Cells 1994; 12: 289–303 .

3 Gordeuk VR , Boyd RD , Brittenham GM . Dietary iron overload persist in rural sub-Saharan Africa . Lancet 1986; 1: 1310–1313 .

4 Ponka P. Rare causes of hereditary iron overload . Sem Hematol 2002; 4: 249–262 .

5 Hash RB . Hereditary haemochromatosis . J Am Board Fam Pract 2001; 4: 266–273 .

6 Dadone M , Kushner JP , Edwards CQ , Bishop DT , Skolnick MH . Hereditary haemochromatosis: analysis of laboratory expression of the disease by genotype in 18 pedigrees . Am J Clin Pathol 1982; 78: 196–207 .

7 Gordeuk VR , Bacon BR , Brittenham GM . Iron overload: causes and consequences . Ann Rev Nutr 1987; 7: 485–503 .

8 Bothwell TH , Seftel H , Jacobs P , Torrance JD , Baumslag N. Iron overload in Bantu subjects. Studies on availability of iron in Bantu beer . Am J Clin Nutr 1964; 14: 47–51 .

9 Mclaren GD , Muir WA , Kellermeyer RW . Iron overload disorders: natural history, pathogenesis, diagnosis and therapy . Crit Rev Clin Lab Sci 1983; 19: 205–266 .

10.

10 Stevens RG , Granbard BI , Micozzi MS , Neriishi K , Blumberg BS . Moderate elevation attention of body iron level and increased risk of cancer occurrence and death . Int J Cancer 1994; 56: 364–369 .

11.

11 Selby JV , Friedman GD . Epidemiologic evidence of an association between body iron stores and risk of cancer . Int J Cancer 1988; 41: 677–682 .

12.

12 Rezazadeh H , Athar M. Evidence that iron overload promotes 7,12-dimethylbenz(a)antheracene-induced skin tumorigenesis in mice . Redox Rep 1998; 3: 303–309 .

13.

13 Rezazadeh H , Julka PK , Athar M. Iron overload augments 12,7-dimethylbenz(a)anthracine-initiated and 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumorigenesis . Skin Pharmacol Appl Skin Physiol 1998; 11: 98–103 .

14.

14 Rezazadeh H , Athar M. Effect of iron overload on benzoyl peroxide-mediated tumour promotion in mouse skin . Cancer Letts 1998; 126: 135–142 .

15.

15 Rezazadeh H , Nayebi AR , Athar M. Role of irondextran on 7,12-dimethylbenz(a) anthracene-initiated and croton oil-promoted cutaneous tumorigenesis in normal and pregnant mice . Hum Exp Toxicol 2001; 20: 471–476 .

16.

16 Delazar A , Babaei H , Rezazadeh H. Inhibitory effect of tannic acid from nutgall on iron-dextran augmented 7,12-dimethylbenz(a) anthracene-initiated and croton oil-promoted skin carcinogenesis . Daru J Fac Pharm Tehran Univ Med Sci 2003; 11: 63–67 .

17.

17 Wright JR , Colby HD , Miles PR . Cytosolic factors which affect microsomal lipid peroxidation in lung and liver . Arch Biochem Biophys 1981; 206: 296–304 .

18.

18 Perchellet EM , Gali HU , Gao XM , Perchellet JP . Ability of the nonphorbol ester-type tumour promoter thapsiagargin to mimic the stimulatory effects of 12-O-tetradecanoylphorbol-13-acetate on ornithine decarboxylase activity, hydroperoxide production, and macromolecule synthesis in mouse epidermis in vivo . Int J Cancer 1993; 55: 1036–1043 .

19.

19 Kano S , Iisuka T , Ishimura Y , Fujiki H , Sugimura T. Stimulation of superoxide anion formation by the non-TPA-type tumour promoters palytoxin and thapsigargin in porcine and human neutrophils . Biochem Biophys Res Commun 1987; 143: 672–677 .

20.

20 Gaey CI , Ziboh VA , MarceloI CI , Voorhees JJ . Modulation of phospholipid metabolism in murine keratinocytes by tumour promoters 12-O-tetradecanoyl phorbol 13-acetate . J Invest Dermatol 1985; 85: 319–323 .

21.

21 Ford-Hutchinson AW . Arachidonic acid metabolism: enzymatic pathways. In Ruzick T ed. Eicosanoids and the skin. Boca Raton, FL: CRC Press , 1990: 3-3.

22.

22 Sun Y. Free radicals, antioxidant enzymes and carcinogenesis . Free Rad Biol Med 1990; 8: 583–599 .

23.

23 Cerutti P. Prooxidant states and tumour promotion . Science 1985; 227: 375–381 .

24.

24 Fukuda A , Osawa T , Hitomi K , Uchida K. 4-Hydroxy-2-nonenal cytotoxicity in renal proximal tubular cells: protein modification and redox alteration . Arch Biochem Biophys 1996; 333: 419–426 .

25.

25 Toyokuni S , Miyake N , Hiai H , Hagiwara M , Kawakishi S , Osawa T , Uchida K. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct . FEBS Letts 1995; 359: 189–191 .

26.

26 Toyokuni S , Uchida K , Okamato K , Hattori-Nakakuki Y , Hiai H , Stadtman ER . Formation of 4-hydroxy-2-nonenal modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate . Proc Natl Acad Sci USA 1994; 91: 2616–2620 .

27.

27 Giri U , Sharma SD , Abdulla M , Athar M. Evidence that in situ generated active oxygen species act as potent stage-I tumour promoter in mouse skin . Biochem Biophys Res Commun 1995; 209: 698–705 .

28.

28 Kramer-Stickland K , Edward A. Inhibitory effect of deferoxamine on UVB-induced Ap-1 trans activation . Carcinogenesis 1999; 20: 2137–2142 .